Mechanistically, ATP6V0D2 binds to STX17 and VAMP8, promoting SNARE protein-mediated autophagosome-lysosome fusion, which was also validated in ccRCC cell lines. Here, STX17 is linked to nonpapillary renal cell carcinoma.